Semaglutide GLP-1, initially developed for managing type 2 diabetes, has been FDA-approved since June 2021 for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related condition such as hypertension, type 2 diabetes, or hyperlipidemia
For medications with flexible timing (liraglutide, weekly formulations), providers often suggest patients begin with the timing that best fits their schedule and monitor for side effects
For those seeking a more affordable option, oral supplements, topical serums, and lifestyle changes can provide steady support for skin health without the risks of infusion therapy
Watch the weight fall off, and easily renew online when its time GLP-1 Rx drug products require an assessment from a licensed healthcare provider who will determine if the medication is appropriate
What exactly are semaglutides, tirzepatides, and GLP-1s